Seaport Therapeutics Stock Forecast

Stock Price Forecast

According to 4 analysts polled by S&P Global, Seaport Therapeutics stock has a consensus rating of "Strong Buy" and an average price target of $35. The average 1-year stock price forecast is 92.63% higher than the current stock price, while the lowest is $30 (+65.11%) and the highest is $40 (+120.14%).

Price Target: $35 (+92.63%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$30	$35	$35	$40
Change	+65.11%	+92.63%	+92.63%	+120.14%

Analyst Ratings

The average analyst rating for Seaport Therapeutics stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	May '26	Jun '26
Strong Buy	3	3
Buy	1	1
Hold	0	0
Sell	0	0
Strong Sell	0	0
Total	4	4

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Paul Matteis Stifel Nicolaus	Stifel Nicolaus	Buy Reiterates $30	Buy	Reiterates	$30	+65.11%	Jun 9, 2026
Tessa Romero J.P. Morgan	J.P. Morgan	Buy Reiterates $42	Buy	Reiterates	$42	+131.15%	Jun 9, 2026
Yigal Nochomovitz Citi	Citi	Buy Reiterates $35	Buy	Reiterates	$35	+92.63%	Jun 9, 2026
Marc Goodman Leerink Partners	Leerink Partners	Buy Initiates $35	Buy	Initiates	$35	+92.63%	May 26, 2026

Financial Forecast

Revenue This Year

n/a

Revenue Next Year

n/a

EPS This Year

-6.50

EPS Next Year

-2.46

from -6.50

Fiscal Year	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	-	-	-
Operating Income	-52.42M	-85.40M	-128.51M
Net Income	-46.88M	-74.88M	-119.54M
EPS	-	-	-6.50
Free Cash Flow	-	-50.78M	-113.00M
No. Analysts	-	-	3

EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue	2026	2027	2028
High	n/a
Avg	n/a
Low	n/a

Revenue Growth

Revenue Growth	2027	2028
High	-
Avg	-
Low	-

EPS Forecast

EPS	2026	2027	2028
High	-2.96
Avg	-6.50
Low	-12.07

EPS Growth

EPS Growth	2027	2028
High	-
Avg	-
Low	-